secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantheus Holdings, Inc. (LNTH)
CIK:        0001521036
Form:       8-K
Filed at:   2024-01-09T23:59:59+00:00
Accession:  0001628280-24-000888
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lantheus pre-announces FY2023 revenue ~$1.296B, beating guidance; PYLARIFY up 62%
--------------------------------------------------------------------------------

- Worldwide revenue expected $1.295-1.297B, up 38-39% YoY, above prior guidance of $1.255-1.270B.
- PYLARIFY revenue $851-853M (+61-62% YoY); DEFINITY ~$279M (+14%); includes $15M RELISTOR milestone.
- Company cites over 6 million patients impacted and strong radiopharmaceutical platform momentum.
- Full FY2023 results and 2024 financial expectations to be released in late February 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1521036/000162828024000888/0001628280-24-000888-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1521036/000162828024000888/lnth-20240109.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-000888

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer